Viewing Study NCT04017832


Ignite Creation Date: 2025-12-24 @ 9:57 PM
Ignite Modification Date: 2026-02-21 @ 5:12 AM
Study NCT ID: NCT04017832
Status: COMPLETED
Last Update Posted: 2024-10-01
First Post: 2019-07-11
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Research Study Comparing a New Medicine Oral Semaglutide to Sitagliptin in People With Type 2 Diabetes
Sponsor: Novo Nordisk A/S
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: NN9924-4309
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators